financetom
Business
financetom
/
Business
/
RateGain Travel IPO listing: New bookings beating pre-pandemic levels; bullish on orderbook, says management
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RateGain Travel IPO listing: New bookings beating pre-pandemic levels; bullish on orderbook, says management
Dec 17, 2021 6:33 AM

New bookings are beating pre-pandemic levels, said Bhanu Chopra, chairman and managing director of RateGain Travel Technologies, on Friday, adding that “65 percent of revenues come from the US.”

However, he said, some sign of weakness in the European markets is visible but have no significant impact on the US revenues.

Also Read: Travel will be next sectoral theme; expect 25% growth in 4-5 years: RateGain Travel

Chopra feels good about the orderbook that’s built.

Also Read: RateGain Travel shares list on BSE, NSE at 15% discount to issue price

RateGain Travel Technologies shares made a subdued debut in the secondary market on Friday. The stock of the software as a service (SaaS) company debuted at Rs 364.8 on BSE, a discount of 14.2 percent to its issue price of Rs 425. On NSE, RateGain Travel shares opened at Rs 360, a discount of 15.3 percent.

For the entire interview, watch the video

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
Oct 12, 2025
LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of Americans. The hard work had paid off, allowing Soriot to clinch the first agreement for a non-U.S. drugmaker and shield his Anglo-Swedish company from threatened steep tariffs on...
FOCUS-Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
FOCUS-Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump
Oct 12, 2025
* AstraZeneca ( AZN ) is second drugmaker to clinch Trump deal * CEO Soriot charm offensive began post-2024 US election * Soriot's strategic moves spare company from tariffs * $4.5 billion Virginia plant boosted goodwill with Trump By Maggie Fick LONDON, Oct 12 (Reuters) - AstraZeneca ( AZN ) CEO Pascal Soriot looked relaxed standing in the Oval Office...
Three workers died at Hyundai's Georgia plant since 2022, before US immigration raid, WSJ reports
Three workers died at Hyundai's Georgia plant since 2022, before US immigration raid, WSJ reports
Oct 12, 2025
Oct 12 (Reuters) - Three workers have died since Hyundai Motor ( HYMLF ) started construction of its $7.6 billion auto plant in Georgia in 2022, the Wall Street Journal reported on Sunday, citing a review of federal records. Dozens of the company's current and former workers, many of them safety coordinators who helped oversee construction, told the newspaper in...
Three workers died at Hyundai's Georgia plant since 2022, before US immigration raid, WSJ reports
Three workers died at Hyundai's Georgia plant since 2022, before US immigration raid, WSJ reports
Oct 12, 2025
(Reuters) -Three workers have died since Hyundai Motor ( HYMLF ) started construction of its $7.6 billion auto plant in Georgia in 2022, the Wall Street Journal reported on Sunday, citing a review of federal records.  Dozens of the company's current and former workers, many of them safety coordinators who helped oversee construction, told the newspaper in interviews that the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved